Ribavirin aerosol in hospitalized adults with respiratory distress and COVID‐19: An open‐label trial

There is an unmet medical need for effective treatments for hospitalized patients with coronavirus disease 2019 (COVID‐19). Ribavirin is a broad‐spectrum antiviral with demonstrated in vitro activity against multiple viruses, including severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Poulakou, Garyfallia, Barakat, Maxime, Israel, Robert J., Bacci, Marcelo R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841304/
https://www.ncbi.nlm.nih.gov/pubmed/36326174
http://dx.doi.org/10.1111/cts.13436

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841304/
https://www.ncbi.nlm.nih.gov/pubmed/36326174
http://dx.doi.org/10.1111/cts.13436

Ejemplares similares